Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
QIAGEN N.V. announces successful placement of new net share settled convertible bonds
Sep 03, 2024•almost 2 years ago
Contract Type
partnership
VenloHealth CareDescription
QIAGEN N.V. has announced certain terms of the new senior, unsecured net share settled convertible bonds, which may be converted into ordinary shares of QIAGEN due 2031. The size of the offering has been increased to $500 million aggregate principal amount, with a coupon of 2.500% per annum and an initial conversion price set at a 44.0% premium over the reference share price.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months